ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.72
      0.00%
      Bitcoin
      98,062.66
      0.31%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Rani Therapeutics Holdings Inc (RANI) Quote

      Rani Therapeutics Holdings Inc

      Rani Therapeutics Holdings Inc (RANI)

      NASDAQ
      1.40
      0.10
      (7.69%)
      Closed December 21 4:00PM
      Delayed by 15 minutes
      1.4199
      0.0199
      (1.42%)
      After Hours: 6:36PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.4199
      Bid
      1.39
      Ask
      1.42
      Volume
      453,989
      1.30 Day's Range 1.415
      1.30 52 Week Range 8.75
      Market Cap
      81.344M
      Previous Close
      1.30
      Open
      1.33
      Last Trade
      1
      @
      1.42
      Last Trade Time
      Financial Volume
      $ 620,480
      VWAP
      1.3667
      Average Volume (3m)
      1,973,800
      Shares Outstanding
      57,288,682
      Dividend Yield
      -
      PE Ratio
      -2.38
      Earnings Per Share (EPS)
      -0.59
      Revenue
      -
      Net Profit
      -33.97M

      About Rani Therapeutics Holdings Inc

      Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.ranitherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RANI. The last closing price for Rani Therapeutics was $1.30. Over the last year, Rani Therapeutics shares have traded in a share price range of $ 1.30 to $ 8.75.

      Rani Therapeutics currently has 57,288,682 shares outstanding. The market capitalization of Rani Therapeutics is $74.48 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -2.38.

      Ask ADVFN Intelligence (AI)

      RANI Latest News

      More News

      FeaturedHertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing

      22 hours ago

      Form 4 - Statement of changes in beneficial ownership of securities

      December 17 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 17 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 16 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 10 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 14 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 14 2024
      Edgar (US Regulatory)

      Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

      - Completed two equity offerings with total gross proceeds of approximately $20.0 million; cash runway extended into 3Q 2025 - - Announced new preclinical pharmacokinetic data supporting...

      November 14 2024
      GlobeNewswire Inc.

      Rani Therapeutics to Participate in Upcoming Investor Conferences

      SAN JOSE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

      November 07 2024
      GlobeNewswire Inc.

      Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

      -Transenteric delivery of incretin triagonist GLP-1, GIP, glucagon receptors mimicking the RaniPill route of administration elicits rapid weight loss and bioavailability comparable to subcutaneous...

      October 17 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.3415-19.38798682871.76141.76141.37937951.46537615CS
      4-0.6601-31.73557692312.082.161.35531641.76520026CS
      12-0.7001-33.02358490572.123.751.319738002.68020252CS
      26-2.4801-63.59230769233.94.371.39397732.69118906CS
      52-1.7001-54.49038461543.128.751.35332632.94137895CS
      156-16.3601-92.014060742417.7827.131.32145823.73255529CS
      260-9.8401-87.389875666111.2636.271.32137075.54030954CS

      RANI - Frequently Asked Questions (FAQ)

      What is the current Rani Therapeutics share price?
      The current share price of Rani Therapeutics is $ 1.4199
      How many Rani Therapeutics shares are in issue?
      Rani Therapeutics has 57,288,682 shares in issue
      What is the market cap of Rani Therapeutics?
      The market capitalisation of Rani Therapeutics is USD 74.48M
      What is the 1 year trading range for Rani Therapeutics share price?
      Rani Therapeutics has traded in the range of $ 1.30 to $ 8.75 during the past year
      What is the PE ratio of Rani Therapeutics?
      The price to earnings ratio of Rani Therapeutics is -2.38
      What is the reporting currency for Rani Therapeutics?
      Rani Therapeutics reports financial results in USD
      What is the latest annual profit for Rani Therapeutics?
      The latest annual profit of Rani Therapeutics is USD -33.97M
      What is the registered address of Rani Therapeutics?
      The registered address for Rani Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Rani Therapeutics website address?
      The website address for Rani Therapeutics is www.ranitherapeutics.com
      Which industry sector does Rani Therapeutics operate in?
      Rani Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MYSZMy Size Inc
      $ 4.2001
      (211.12%)
      		121.03M
      NVNINVNI Group Ltd
      $ 8.26
      (209.36%)
      		78.06M
      TPICTPI Composites Inc
      $ 2.45
      (100.82%)
      		34M
      ICGIntchains Group Ltd
      $ 8.77
      (88.60%)
      		527.94k
      HSDTHelius Medical Technologies Inc
      $ 0.884851
      (84.34%)
      		121.95M
      CYNCYNGN Inc
      $ 0.4603
      (-71.41%)
      		27.5M
      MTEMMolecular Templates Inc
      $ 0.1502
      (-57.09%)
      		8.63M
      PRFXPainReform Ltd
      $ 5.15
      (-53.85%)
      		2.84M
      GALTGalectin Therapeutics Inc
      $ 1.03
      (-48.50%)
      		8.58M
      BCABBioAtla Inc
      $ 0.6923
      (-41.82%)
      		5.96M
      EDBLEdible Garden AG Inc
      $ 0.24
      (65.06%)
      		354.33M
      NVDANVIDIA Corporation
      $ 134.70
      (3.08%)
      		310.19M
      APTOAptose Biosciences Inc
      $ 0.28
      (64.51%)
      		306.25M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.606999
      (6.49%)
      		293.22M
      PLTRPalantir Technologies Inc
      $ 80.55
      (8.54%)
      		281.23M

      RANI Discussion

      View Posts
      PonkenPlonken PonkenPlonken 5 days ago
      neglected
      cant get no love. Had hopes once because of the oral administration GLP1 platform
      people dont like needles
      👍️0
      David bond David bond 2 months ago
      There are no short shares available as of 11.45 am....dont sell I believe a shore squeeze will happen today if not then in the morning
      👍️0
      1hot toddy 1hot toddy 2 months ago
      AVERAGE PRICE OF 5 ANALYSIS IS $12 $$$$$$$$$$$$
      👍️0
      1hot toddy 1hot toddy 2 months ago
      16000 SHARES ON THE BID $$$$$$$$$$ BACK OVER $3 $$$$$$$$$$$$$$$
      👍️0
      David bond David bond 2 months ago
      Don't listen to woodpecker he is obvious short selling and likes to make up stories
      👍️0
      David bond David bond 2 months ago
      Don't listen to woodpecker he is obvious short selling and likes to make up stories
      👍️0
      Woodpecker3 Woodpecker3 2 months ago
      In the course of your due diligence did you read that the company is at risk of not being able to continue as an on-going concern? This was in the 10Q from June 2024. I would also take a look at the balance sheet and income statement. There you will realize $RANI is teetering on the brink of bankruptcy. It has no product, has multi million dollar losses for the last several years the most recent one 67 million $. It is burning through its cash. Caveat Emptor...Buyer beware
      👍️0
      1hot toddy 1hot toddy 2 months ago
      investor bought the 3 mil shares at $3. its now 2.40 so we get to buy lower. great news for co as they get $10 mil. its takes money to make money. co at money making phase and employees bought big time. this is guaranteed to go up rest of week. i got my money on it and average price of 5 analysis is $12 $$$$$$$$$
      👍️0
      Woodpecker3 Woodpecker3 2 months ago
      So the plot thickens.. RANI was prepping itself for the share and warrant offered today to Maxim Group. RANI is running out of cash. Without revenues and no guarantee of ever having a product to sell, RANI is scrambling for the pending reality that it will be unable to run as an ongoing concern. This was noted in its 10Q to the SEC in June.
      👍️0
      Woodpecker3 Woodpecker3 2 months ago
      RANI Therapeutics 10Q to Securities and Exchange Commission stated that due to liquidity issues there is substantial doubt regarding the company's ability to continue as a going concern. (See link below to SEC 10Q and read page 10)

      https://www.marketwatch.com/investing/stock/rani/financials/secfilings?docid=17734871
      👍️0
      Woodpecker3 Woodpecker3 2 months ago
      There is substantial doubt regarding the Company’s ability to continue as a going concern

      The Company has incurred recurring losses since its inception, including net losses of $28.1 million for the six months ended June 30, 2024. As of June 30, 2024, the Company had an accumulated deficit of $87.2 million and for the six months ended June 30, 2024, had negative cash flows from operations of $18.4 million. As of June 30, 2024, cash, cash equivalents and marketable securities totaled $30.9 million. Based on its available cash resources and current operating plan, there is substantial doubt regarding the Company’s ability to continue as a going concern for a period of one year after the date that its financial statements for the six months ended June 30, 2024 are issued.
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      Im baffled. See the post I am replying too-- was in broad daylight. And only now discovered via this stoopid Oppenheimer note LOL
      I love fundamental analysis!!!! So rewarding!
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      oral GLP1...... boom
      👍️0
      Invest-in-America Invest-in-America 2 months ago
      RANI: If Oppenheimer says so, right?????
      👍️0
      Monksdream Monksdream 4 months ago
      RANI under $4
      👍️0
      PonkenPlonken PonkenPlonken 7 months ago
      MGRX did 330% today on news of planning to distribute an oral version of GLP1 sometime in the future.
      This company has the platform to produce a promising oral GLP1 option right now.

      You also get some free shots at the goal in 4 other indications.
      👍️0
      Monksdream Monksdream 8 months ago
      RANI under $10
      👍️0
      PonkenPlonken PonkenPlonken 8 months ago
      wants sooo much more
      👍️0
      PonkenPlonken PonkenPlonken 8 months ago
      shake shake the tree
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...HERE COMES 9.00...LOL
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...8 DOLLA FLOOR BEING BUILT
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI 8 DOLLA...FORTUNE COOKIE WAS RIGHT....LMAO
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...LETS SEE 8 BUCKS
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      SOMEONE WITH BRAINS AROUND HERE
      👍️ 1
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...GAPPING TO 7.50...LMAO...WHAT A CALL FROM THE HOUSE OF TREND
      👍️0
      PonkenPlonken PonkenPlonken 8 months ago
      $RANI can clear worries about GLP adm.
      No sellers in consecutive sessions.
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      ITS RAINING AGAIN WITH RANI...IS TIM ON THIS ONE?!!
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...LET THEM CHASE THE ALGO FABRICATIONS WHILE WE WATCH RANI TREND TO 7.00
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...HERE COMES 7.00
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...BREAKING NEW HIGH
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...BREAKING 6.00...BIO BEAST!!!
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...ITS RAINING AGAIN
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...HERE WE GO
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI....BIO MONSTER
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...THIN AS THIN...ARCA BID
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      RANI...NEXT BIO BEAST READY TO BEAST
      👍️0

      Your Recent History

      NASDAQ
      RANI
      Rani Therapeutics
      NASDAQ
      PRCT
      PROCEPT BioRobotics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads